James Butler

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Rrp6, Rrp47 and cofactors of the nuclear exosome
    J Scott Butler
    Department of Microbiology and Immunology, Center for RNA Biology from Genome to Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Adv Exp Med Biol 702:91-104. 2010
  2. ncbi Rrp6, rrp47 and cofactors of the nuclear exosome
    J Scott Butler
    Departments of Microbiology and Immunology, and Biochemistry and Biophysics, and Center for RNA Biology from Genome to Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Adv Exp Med Biol 702:91-104. 2011

Research Grants

  1. NUCLEAR PATHWAY FOR MESSENGER RNA DEGRADATION IN YEAST
    James Butler; Fiscal Year: 2002
  2. The Yeast Exosome as a Model Anticancer Drug Target
    James Butler; Fiscal Year: 2004

Collaborators

Detail Information

Publications2

  1. ncbi Rrp6, Rrp47 and cofactors of the nuclear exosome
    J Scott Butler
    Department of Microbiology and Immunology, Center for RNA Biology from Genome to Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Adv Exp Med Biol 702:91-104. 2010
    ..The details that govern the specificity of these decisions remain a rich source for future investigation...
  2. ncbi Rrp6, rrp47 and cofactors of the nuclear exosome
    J Scott Butler
    Departments of Microbiology and Immunology, and Biochemistry and Biophysics, and Center for RNA Biology from Genome to Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Adv Exp Med Biol 702:91-104. 2011
    ..The details that govern the specificity of these decisions remain a rich source for future investigation...

Research Grants7

  1. NUCLEAR PATHWAY FOR MESSENGER RNA DEGRADATION IN YEAST
    James Butler; Fiscal Year: 2002
    ....
  2. The Yeast Exosome as a Model Anticancer Drug Target
    James Butler; Fiscal Year: 2004
    ..8S rRNA processing. These experiments should clarify the connection between 5FU and rRNA processing and therefore provide a new pathway to which anticancer drugs can be targeted. ..